1. Home
  2. PCG vs ALC Comparison

PCG vs ALC Comparison

Compare PCG & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacific Gas & Electric Co.

PCG

Pacific Gas & Electric Co.

SELL

Current Price

$13.03

Market Cap

36.0B

Sector

Utilities

ML Signal

SELL

Logo Alcon Inc.

ALC

Alcon Inc.

SELL

Current Price

$66.10

Market Cap

34.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PCG
ALC
Founded
1995
1945
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Power Generation
Ophthalmic Goods
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.0B
34.1B
IPO Year
2000
2002

Fundamental Metrics

Financial Performance
Metric
PCG
ALC
Price
$13.03
$66.10
Analyst Decision
Buy
Buy
Analyst Count
17
27
Target Price
$18.50
★ $82.73
AVG Volume (30 Days)
★ 33.2M
1.7M
Earning Date
10-22-2026
11-10-2026
Dividend Yield
★ 1.54%
0.35%
EPS Growth
★ 2.61
N/A
EPS
★ 0.72
N/A
Revenue
★ $24,935,000,000.00
N/A
Revenue This Year
$4.77
$6.64
Revenue Next Year
$3.88
$6.07
P/E Ratio
★ $18.01
$38.31
Revenue Growth
★ 2.11
N/A
52 Week Low
$11.77
$61.84
52 Week High
$19.16
$87.64

Technical Indicators

Market Signals
Indicator
PCG
ALC
Relative Strength Index (RSI) 45.88 52.52
Support Level $12.59 $66.08
Resistance Level $13.69 $68.25
Average True Range (ATR) 0.37 0.99
MACD 0.21 0.46
Stochastic Oscillator 66.49 81.91

Price Performance

Historical Comparison
PCG
ALC

About PCG Pacific Gas & Electric Co.

PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision in 2001-04 during California's energy crisis and in 2019-20 due to wildfire losses. In 2004, PG&E sold its unregulated assets as part of its first postbankruptcy reorganization.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: